Science Media Centre

Science Media Centre

In the News

PHARMAC funds genetically-targeted Hep C drug

John Kerr posted in on August 22nd, 2013.

PHARMAC has announced it will fund a new hepatitis C drug targeted to patients who carry a particular gene variant, highlighting the rise of personalised medicine. The government drug buying agency will begin funding boceprevir (Victrelis) from next month for certain patients for the treatment of hepatitis C in combination with other drugs. The treatment […]

Copyright 2017 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy